Summit Therapeutics begins Phase II/III HARMONi-GU1 study of ivonescimab
Summit Therapeutics has expanded its clinical programme for ivonescimab with the Phase II/III HARMONi-GU1 study to assess its use in…
All articles by Salong Debbarma
Salong Debbarma
-
-
SystImmune doses first patient in Phase III trial for ES-SCLC
SystImmune has dosed the first patient in its global Phase III clinical trial, BrenDeLL-Lung01, assessing BL-M14D1 combined with atezolizumab in…
-
ABLi reports biomarker findings from risvodetinib study for Parkinson’s
ABLi Therapeutics has completed a detailed biomarker analysis of risvodetinib for Parkinson’s disease (PD) covering 7,300 individual metrics from up…
-
Evexta Bio and Roche plan Phase Ib trial of rupitasertib with giredestrant
Evexta Bio and Roche have entered a clinical trial collaboration and supply agreement for a Phase Ib study investigating the…
-
Enrolment concludes in 4Moving Biotech’s Phase IIa trial of 4P004
4Moving Biotech has completed patient enrolment in its Phase IIa INFLAM MOTION trial of 4P004, an intra-articular glucagon-like peptide-1 (GLP-1)…
-
Ascletis receives FDA clearance to begin Phase III ASC30 programme
Ascletis Pharma has initiated a global Phase III clinical programme for its once-daily oral small molecule glucagon-like peptide-1 (GLP-1) receptor…
-
Diakonos Oncology doses first patients in DOC-RM trial
Diakonos Oncology has dosed the first patients in its Phase I/II DOC-RM clinical trial of DOC1021 (dubodencel) for refractory melanoma.…
-
Moleculin reports interim results from MIRACLE trial in r/r AML patients
Moleculin Biotech has reported preliminary blinded data from Part A of its ongoing pivotal Phase II/III MIRACLE trial assessing Annamycin…
-
Karyopharm’s XPORT-EC-042 study fails to meet primary endpoint
Karyopharm Therapeutics’ Phase III XPORT-EC-042 clinical trial assessing selinexor has failed to meet its primary endpoint of progression-free survival (PFS)…
-
Evommune begins Phase IIb trial of EVO756 for migraine
Evommune has initiated a Phase IIb clinical trial of EVO756 for the prophylactic migraine treatment with the dosing of the…